Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D

by Osinusi, Anu , Da, Ben L. , Pântea, Victor , Hilleret, Marie-Noëlle , Lampertico, Pietro , Stepanova, Tatyana , Chee, Grace , Morozov, Viacheslav , Lau, Audrey H. , Ye, Lei , Lazar, Stefan , Syutkin, Vladimir , Sagalova, Olga , Wedemeyer, Heiner , Streinu-Cercel, Adrian , Zoulim, Fabien , Bourliere, Marc , Ratziu, Vlad , Bogomolov, Pavel , Pol, Stanislas , Chulanov, Vladimir , Gherlan, George S. , Asselah, Tarik , Manuilov, Dmitry , Mercier, Renee-Claude , Placinta, Gheorghe

in Adult / Adverse events / Antiviral Agents - administration & dosage / Antiviral Agents - adverse effects / Antiviral Agents - therapeutic use / Antiviral drugs / Clinical medicine / Clinical practice guidelines / Confidence intervals / Drug Therapy, Combination / Female / Gastroenterology / Gastroenterology General / Hepatitis / Hepatitis B / Hepatitis D, Chronic - drug therapy / Hepatitis delta virus / Hepatitis Delta Virus - drug effects / Hepatitis Delta Virus - genetics / Hepatitis Delta Virus - isolation & purification / Humans / Infections / Infectious Disease / Infectious Disease General / Interferon / Interferon-alpha - administration & dosage / Interferon-alpha - adverse effects / Interferon-alpha - therapeutic use / Leukopenia / Liver cirrhosis / Liver Disease / Liver diseases / Male / Middle Aged / Neutropenia / Recombinant Proteins - administration & dosage / Recombinant Proteins - adverse effects / Recombinant Proteins - therapeutic use / Ribonucleic acid / RNA / RNA viruses / RNA, Viral - blood / Thrombocytopenia / Viral Infections / Viral Load

2024

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D

2024

Confirm

Do you wish to request the book?

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D

2024

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D

Osinusi, Anu,

Da, Ben L.,

Pântea, Victor,

Hilleret, Marie-Noëlle,

Lampertico, Pietro,

Stepanova, Tatyana,

Chee, Grace,

Morozov, Viacheslav,

Lau, Audrey H.,

Ye, Lei,

Lazar, Stefan,

Syutkin, Vladimir,

Sagalova, Olga,

Wedemeyer, Heiner,

Streinu-Cercel, Adrian,

Zoulim, Fabien,

Bourliere, Marc,

Ratziu, Vlad,

Bogomolov, Pavel,

Pol, Stanislas,

Chulanov, Vladimir,

Gherlan, George S.,

Asselah, Tarik,

Manuilov, Dmitry,

Mercier, Renee-Claude,

Placinta, Gheorghe

2024

Overview

In a phase 2 trial, 10-mg bulevirtide plus pegylated interferon alfa-2a was superior to bulevirtide alone with regard to an undetectable HDV RNA level 24 weeks after the end of treatment in patients with chronic hepatitis D.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Adult

/ Adverse events

/ Antiviral Agents - administration & dosage

/ Antiviral Agents - adverse effects

/ Antiviral Agents - therapeutic use

/ Antiviral drugs

/ Clinical medicine